News

Synergy Pharma said that SP-304 is a member of a new class of non-systemic drugs for treatment of chronic constipation (CC), irritable bowel syndrome with constipation (IBS-C) and

Ovaprene is a ‘one-size-fits-all’ patented, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period. Reportedly, a Phase

Promega’s Maxwell 16 IVD System works to the specific needs of a clinical lab. Addressing the pressure to deliver quick results, especially in the process to determine organ

The asthma programme for Relovair (previously referred to as ‘Horizon’) will assess the potential benefit of the combination of inhaled corticosteroid, fluticasone furoate and long-acting beta agonist vilanterol

Somaxon Pharma has said that Silenor has not been designated as a controlled substance by the US Drug Enforcement Administration (DEA) because of its demonstrated lack of abuse

The arrangement provides Haemonetics with exclusive access to Alba’s comprehensive catalogue of approved reagents for use in connection with the commercialization of its Arryx laser based blood typing

FDA’s warning highlights the greater risk of developing muscle injury, including rhabdomyolysis, for patients when they are prescribed and use higher doses of Zocor drug. Simvastatin is sold

Tepadina can be used to treat haematological diseases such as leukaemia, lymphoma, multiple myeloma and thalassemia and also specific solid tumours (eg breast cancer, CNS tumours, ovarian cancer

Both Affinity and JSW are expected to continue to offer their products and services under strict quality control measurements which meet government and regulatory requirements such as FDA,